Multi-domain efforts to curb bacterial resistance are exploring new antibiotics.

Global use of antimicrobial drugs has increased by 36% in the past decade.
, 10 million people worldwide may die from antibiotic resistance by 2050 if they are not prevented.
Today, at the shanghai Microbiological Society Microbial Resistance Prevention and Control Committee set up and microbial infection diagnosis technology seminar, experts once again stressed that antimicrobial resistance has brought great challenges to clinical treatment, if not standardized and rational use of antimicrobial drugs, the future will be no drugs available.
2016, China used 162,000 tons of antimicrobial drugs a year, accounting for half of the world's use, according to data released by the U.S. Government.
30% of hospital admissions, especially in China, accounting for 80-90%.
Shanghai Microbiological Society, the first chairman of the Microbial Resistance Prevention and Control Committee, Ruijin Hospital Clinical Microbiology Department, hospital infection prevention and management department director Professor Yuxing pointed out that, on the one hand, the rapid spread of bacterial resistance, some diseases have emerged a wide range of drug-resistant bacteria, this type of bacteria is only sensitive to one or two existing drugs.
note that drug-resistant bacteria are now most present in ICU and pediatrics.
, on the other hand, what worries doctors is that research and development of new drugs is decreasing or even drying up year by year.
analysis, this is related to the increased difficulty of research and development, research and development costs, cheap drugs difficult to make a profit and other factors.
, how serious are the consequences of antimicrobial resistance? What do "superbugs" bring to humans? Citing the Global Review of Antimicrobial Resistance published by Jim O'Neill of the United Kingdom, Professor Yu said that, if left unguned, antibiotic resistance would kill 10 million people worldwide each year and cost $100 trillion in GDP by 2050;
the evolution and spread of super-resistant bacteria in microorganisms makes the monitoring and control of drug-resistant bacteria urgent.
" Professor Yuxing said that microbial resistance prevention and control needs to monitor important microorganisms, carry out epidemiological investigation and big data analysis, to find out the source of infection, the causes and mechanisms of drug resistance, and ultimately form effective comprehensive control measures to curb the further spread of drug-resistant strains and widespread spread.
requires top-level design, and there is an urgent need for multi-sectoral, multi-d'ethistical and collaborative planning to respond together.
According to reports, the Shanghai Institute of Microbiology Microbial Resistance Prevention and Control Committee will in the future in cooperation with various fields, interdisciplinary scientists, research and development of new antimicrobial drugs, bacterial resistance monitoring, bacterial resistance mechanism research, including human and animal sharing of antimicrobial drugs or antimicrobial drugs prone to cross-resistance monitoring and research.
.